Alcon Inc.

Alcon Posts 5.9 Percent Sales Growth for Third Quarter.(Financial report)
Biotech Week; 11/11/2009; 1667 words; Alcon, Inc. (NYSE:ACL) reported global sales...for the third quarter of 2008 (see also Alcon, Inc.). "Continued execution of our operational...quarter performance," said Kevin Buehler, Alcon's president and chief executive officer...

Zacks Industry Outlook Highlights: Alcon, Novartis, Gilead Sciences, Biogen Idec and Acorda Therapeutics
Zacks Investment Research -; 11/10/2009; 889 words; ...Industry Outlook Highlights: Alcon, Novartis, Gilead Sciences...Biotech sector, including Alcon (ACL), Novartis (NVS...are positive on stocks like Alcon (ACL) and Novartis (NVS...Zacks Investment Research, Inc., which was formed in 1978...

Big Pharma & Biotech - Industry Outlook
Zacks Investment Research - Industry Outlook; 11/10/2009; 1619 words; ...sector is a focus on emerging markets. Companies like Mylan Inc (MYL), GlaxoSmithKline (GSK) and Sanofi-Aventis are all...OPPORTUNITIES In the pharma space, we are positive on stocks like Alcon (ACL) and Novartis (NVS). We believe these companies will...

Big Pharma & Biotech - Zacks Analyst Interviews
Zacks Investment Research - Zacks Analyst Interviews; 11/10/2009; 1624 words; ...sector is a focus on emerging markets. Companies like Mylan Inc (MYL), GlaxoSmithKline (GSK) and Sanofi-Aventis are all...OPPORTUNITIES In the pharma space, we are positive on stocks like Alcon (ACL) and Novartis (NVS). We believe these companies will...

Big Pharma and Biotech - Industry Outlook
Zacks Investment Research - Industry Outlook; 11/9/2009; 1623 words; ...sector is a focus on emerging markets. Companies like Mylan Inc (MYL), GlaxoSmithKline (GSK) and Sanofi-Aventis are all...OPPORTUNITIES In the pharma space, we are positive on stocks like Alcon (ACL) and Novartis (NVS). We believe these companies will...